| | Pathway | Gene count | Gene |
| | Upregulated | Lymphocyte infiltrate | 10 | CCL21, CCL2, CXCR4, PTPRC, IL-10RA, FYB, CD52, SRGN, TYROBP, TNFAIP8 | | Tumor marker | 4 | EGR3, MMP2, PTGS2, ZEB1 | | Cytokine signaling | 4 | IL-6, IL-4, CSF1R, CSF2RB | | Checkpoint pathway | 4 | CD69, PDCD1LG2, CD28, ENTPD1 | | TCR coexpression | 3 | ITK, CD3E, IL-7R | | Adhesion_migration | 3 | NCAM1, ITGA1, ADGRE5 | | Innate_immune_response | 2 | LYZ, AXL | | Antigen_presentation | 2 | CD1C, CD83 | | Type_II_interferon_signaling | 1 | CX3CL1 | | T_cell_regulation | 1 | KLF2 | | T_cell_differentiation | 1 | EGR2 | | PD_1_signaling | 1 | FOXO1 | | NK_cell_marker | 1 | NCR3 | | NK_activation | 1 | KLRG1 | | Myeloid_marker | 1 | MPO | | Lymphocyte_development | 1 | IKZF1 | | Lymphocyte_activation | 1 | SH2D1A | | Leukocyte_migration | 1 | VCAM1 | | Dendritic_cell | 1 | NRP1 |
| | Downregulated | Proliferation | 5 | CCNB2, TOP2A, MAD2L1, KIAA0101, MELK | | Neutrophil | 2 | KREMEN1, DGAT2 | | Checkpoint_pathway | 1 | TNF | | Antigen_processing | 1 | HLA-C | | Tumor_antigen | 1 | BAGE |
|
|
